Applied DNA Sciences Inc. (NASDAQ: APDN) stock gained by 0.17% at last close while the APDN stock price surges by 6.98% in the pre-market trading session. LinearDNA, Applied DNA’s patented large-scale polymerase chain reaction-based manufacturing platform that enables for the large-scale manufacture of particular DNA sequences, is being commercialized.
APDN stock’ Significant Development
Suffolk County Community College has granted a testing deal to Applied DNA Clinical Labs, LLC (ADCL) which is the wholly-owned subsidiary of Applied DNA Sciences. In preparation for the College’s reopening in the autumn, the contract was established to track the incidence of COVID-19 among its unvaccinated employees and professors. The testing will start in the second half of September 2021. The College, which is part of the State University of New York (SUNY) system, follows SUNY’s vaccine policy, which mandates that all on-campus students be completely vaccinated against COVID-19 by September 27, 2021.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
The Contract’s initial duration is one year, with two one-year renewal options available at the College’s discretion. The Contract specifies a fixed monthly cost for sample collection site facilities and a separate fixed fee per each COVID-19 test, but no baseline testing criteria.
Suffolk County Community College is a public community college in Suffolk County, New York, that is partially supported by the county. The college was founded in 1959 and has three locations in New York: Selden, Brentwood, and Riverhead. Around 2,000 full-time and adjunct faculty members work at the university. There are around 25,000 full- and part-time students at the College.
ADCL will use safeCircle, an elevated, pooled COVID-19 testing system, to offer cost-effective COVID-19 testing under the provisions of the deal. The Company’s Linea COVID-19 Assay Kit will be used in a pooled screening modality as well as to execute reflex individual diagnostic testing of samples contained in a positive pool at ACDL’s CLEP/CLIA-certified laboratory. The health verification platform developed by subcontractor CLEARED4 will be utilized for appointments, sample tracking, reporting, program administration, and mobile access pass visibility.